Correlation Engine 2.0
Clear Search sequence regions

Persistent infections involving slow-growing or non-growing bacteria are hard to treat with antibiotics that target biosynthetic processes in growing cells. Consequently, there is a need for antimicrobials that can treat infections containing dormant bacteria. In this Review, we discuss the emerging concept that disrupting the bacterial membrane bilayer or proteins that are integral to membrane function (including membrane potential and energy metabolism) in dormant bacteria is a strategy for treating persistent infections. The clinical applicability of these approaches is exemplified by the efficacy of lipoglycopeptides that damage bacterial membranes and of the diarylquinoline TMC207, which inhibits membrane-bound ATP synthase. Despite some drawbacks, membrane-active agents form an important new means of eradicating recalcitrant, non-growing bacteria.


Julian G Hurdle, Alex J O'Neill, Ian Chopra, Richard E Lee. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nature reviews. Microbiology. 2011 Jan;9(1):62-75

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 21164535

View Full Text